Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02989610 · ClinicalTrials.gov registry record
Clinical Evaluation of the Infinity Deep Brain Stimulation System
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 234
- Enrollment target
NCT02989610 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 234 participants.
The verdict
NCT02989610 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 234 participants
- Enrollment target
Study Summary
The purpose of this post-market study is to characterize the clinical performance of the Infinity Deep Brain Stimulation (DBS) system, including the Implantable Pulse Generator (IPG), directional DBS leads, extensions, iPad clinician programmer, iPod patient controller and related system components. Participants in the PROGRESS study are not assigned to interventional therapy groups. Participants in the PROGRESS study are followed in an observational format as they receive omnidirectional and then directional DBS programming that is part of routine medical care. Data on symptoms are collected during two different stages of programming, and those outcomes compared to assess the effect of omnidirectional or directional programming.
Interventions
- DEVICE Omnidirectional stimulation
- DEVICE Directional stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2017-01-31 |
| Est. Completion | 2022-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02989610
The ClinicalTrials.gov registry entry for NCT02989610 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Omnidirectional stimulation is the first listed.
NCT02989610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02989610 about?
NCT02989610 is a clinical study titled "Clinical Evaluation of the Infinity Deep Brain Stimulation System". The purpose of this post-market study is to characterize the clinical performance of the Infinity Deep Brain Stimulation (DBS) system, including the Implantable Pulse Generator (IPG), directional DBS leads, extensions, iPad clinician programmer, iPod patient controller and related system components....
What is the current status of trial NCT02989610?
This trial is currently completed. The enrollment target is 234 participants. The study started on 2017-01-31. Estimated completion is 2022-04-19.
What interventions are being tested in trial NCT02989610?
The interventions under investigation include: Omnidirectional stimulation (DEVICE), Directional stimulation (DEVICE).
Who is sponsoring clinical trial NCT02989610?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.